Alicia O'Neill
@patients1staon
Director Patient Advocacy, Oncology, GSK; Following cancer advocates, KOLs. Keeping up on news to help patients. Views expressed here are my own not employer
ID: 180430451
https://gsk.com 19-08-2010 16:31:43
351 Tweet
245 Followers
302 Following
7. Masks Universal masking when going out helps prevent because 40% spread is from asymptomatic people. No side effects. Prevents you from spreading. May also protect you some. #Masks4All Cloth masks enough. Jeremy Howard Siddhartha Mukherjee Anna Kaltenboeck tinyurl.com/yage6zgd
8. Antiviral with high efficacy We don’t have one yet. This will be a game changer. Many promising ones are in clinical trials. Remdesivir data leaks are unfortunate, but show it may not be the answer. Matthew Herper
9. Convalescent Plasma: Plasma taken from people who already have COVID and have recovered is promsing. Clinical Trials are ongoing in many places. Michael Joyner Priya Sampathkumar Ramya Kannan Suresh Nambath
12-0 vote from FDA Oncology ODAC panel in favor of GSK belantamab mafodotin for relapsed/refractory #myeloma #mmsm Sagar Lonial MD onclive.com/view/fda-panel…
#iwMyeloma20 Excellent presentation by Dr Trudel from Princess Margaret Cancer Centre Keith Stewart. She pointed out that Belamaf causes symptomatic keratopathy due to micro cyst in 52%. Keratopathy is reversible! Should be monitored by ophthalmology. #mmsm VJHemOnc
Congratulations Dr Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 . The whole myeloma community is very proud of you. You have contributed so much to advance the field and we are very grateful. CarolinaHealth International Myeloma Foundation Multiple Myeloma RF Myeloma UK @MyelomaTeacher - Cindy Chmielewski @theiach
Just throwing it out there, new Philly 10-Miler? Rebecca Barber (she/her) Dan McQuade Jen A. Miller giulio pescatore Britt
Our very own Mary DeRome (Mary DeRome) was recently featured on the inaugural episode of Science on the Sofa. Learn more about the RightTrack approach and how it can benefit myeloma patients.
Naveen Pemmaraju, MD opens day 2 w/explosion of current research. #mpnhz22 “We must go for disease modification … and why not earlier.” MPN Research Foundation
Awesome talk on MPN guidelines and approaches by Dr Gaby Hobbs Gaby Hobbs at our #MPNHz22 meeting in Netanya Israel 🇮🇱 !! 👏🏽 || #MPNSM
To transplant or not for Myelofibrosis? Such a tough question. Today we heard the pros and cons. We heard from experts Dr Naveen Pemmaraju and Dr Martin Ellis Naveen Pemmaraju, MD #MPNHHZ22
👉👉👉Sartorial master & hematologist extraordinaire Aaron Gerds MD, MS presenting long term durability of efficacy seen in MOMENTUM study from momelotinib in regards to spleen reduction/symptom improvement/anemia benefit #ASH22 Naveen Pemmaraju, MD Andrew Kuykendall MD